A5033643885- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Cardiac electrophysiology and arrhythmias
- Sarcoidosis and Beryllium Toxicity Research
- Atrial Fibrillation Management and Outcomes
- Cardiac Structural Anomalies and Repair
- Mechanical Circulatory Support Devices
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Cardiac Imaging and Diagnostics
- Cardiomyopathy and Myosin Studies
- Viral Infections and Immunology Research
- ECG Monitoring and Analysis
- Coronary Interventions and Diagnostics
- Congenital Heart Disease Studies
- Cardiac Valve Diseases and Treatments
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Vascular anomalies and interventions
- Heart Failure Treatment and Management
- Cardiac Arrest and Resuscitation
- Infectious Diseases and Tuberculosis
- Lipoproteins and Cardiovascular Health
- Acute Myocardial Infarction Research
- Occupational exposure and asthma
- Cardiovascular Function and Risk Factors
- Neurological disorders and treatments
University of Minnesota
2015-2024
Medtronic (Ireland)
2024
University of Michigan–Ann Arbor
2022-2024
Virginia Commonwealth University
2022-2024
Minneapolis Heart Institute Foundation
2024
University of Minnesota Medical Center
2013-2023
University Physicians
2023
University of Minnesota System
2013-2021
St. Vincent Hospital
2017
Advocate Christ Medical Center
2017
Left ventricular assist devices (LVADs) are an increasingly used strategy for the management of patients with advanced heart failure reduced ejection fraction. Although these effectively improve survival, atrial and arrhythmias common, predispose to additional risk, complicate patient management. However, there is no consensus on best practices medical or optimal timing procedural interventions in refractory arrhythmias. vast majority have preexisting cardiovascular implantable electronic...
Background: Implantable cardioverter-defibrillators are used to prevent sudden cardiac death in patients with sarcoidosis. The most recent recommendations for implantable cardioverter-defibrillator implantation these the 2017 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline Management Patients With Ventricular Arrhythmias and Prevention Sudden Cardiac Death. These recommendations, based on observational studies or expert opinion, have not been...
In patients with sarcoidosis suspected cardiac involvement, late gadolinium enhancement (LGE) on cardiovascular magnetic resonance imaging (CMR) identifies those an increased risk of adverse outcomes. However, these outcomes are experienced by only a minority LGE, and identifying this subgroup may improve treatment in patients.To assess whether CMR phenotypes based left ventricular ejection fraction (LVEF) LGE (CS) associated during follow-up.This cohort study included consecutive...
Abstract Aims The extravascular implantable cardioverter-defibrillator (EV ICD) has been shown to be safe and effective for patients at risk of sudden cardiac death, but little is known about EV ICD lead removal in humans. This analysis aimed characterize the experience thus far. Methods results was a retrospective removals from Pilot, Pivotal, Continued Access Studies. Patients with successful implant who underwent were included. main objective success. Ancillary objectives included...
Abstract Background Sarcoidosis is a systemic granulomatous disease of unknown etiology. Clinical cohort studies different populations are important to understand the high variability in clinical presentation and course sarcoidosis. The aim study evaluate characteristics, including organ involvement, pulmonary function tests, laboratory parameters, sarcoidosis at University Minnesota. We compare system involvement this with other available cohorts. Methods conducted retrospective data...
Ventricular tachycardia (VT) is associated with high mortality in patients cardiac sarcoidosis (CS), and medical management of CS-associated VT limited by failure rates. The role catheter ablation has been investigated small, single-center studies.To investigate outcomes CS.This cohort study from the Cardiac Sarcoidosis Consortium registry (2003-2019) included 16 tertiary referral centers US, Europe, Asia. A total 158 consecutive CS were (33% female; mean [SD] age, 52 [11] years; 53%...
A definitive dietary preparation recommendation is not possible based on literature the achievement of myocardial suppression for diagnosis cardiac sarcoidosis (CS) with <sup>18</sup>F-FDG PET/CT. Our goal to compare 3 different preparations in best and CS diagnosis. <b>Methods:</b> We retrospectively reviewed compared used at our institution. Three diets were applied from March 2014 December 2019: a 24-h ketogenic diet overnight fasting (<i>n</i> = 94); 18-h 44); 72-h daytime 3-d 98). The...
Many patients with heart failure continue cardiac resynchronization therapy (CRT) after continuous flow left ventricular assist device (CF-LVAD) implant. We report the first multicenter study to assess impact of CRT on clinical outcomes in CF-LVAD patients.
Subcutaneous implantable cardioverter-defibrillators provide an alternative to transvenous defibrillation but require higher shock outputs and offer no antitachycardia pacing. The Substernal Pacing Acute Clinical Evaluation (SPACE) study evaluated the feasibility of pacing from extravascular substernal location.The primary purpose SPACE was characterize space. Secondary objectives included evaluating extracardiac stimulation recording electrograms.The prospectively with a commercially...
P rolonged use of hydroxychloroquine (HCQ) has been implicated in the development conduction disturbances and myocardial dysfunction. 1 We report a case cardiomyopathy after 10 years HCQ therapy 66-yearold woman with systemic lupus erythematosus (SLE).
Background: There are few data on sex differences in suspected cardiac sarcoidosis. Methods: Consecutive patients with histologically proven sarcoidosis and involvement were studied. We investigated presenting features, involvement, the long-term incidence of a primary composite end point all-cause death or significant ventricular arrhythmia secondary points arrhythmia. Results: Among 324 patients, 163 (50.3%) female 161 (49.7%) male patients. Female had greater prevalence chest pain (37.4%...